KEYNOTE-033: Phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (NSCLC)

被引：0

作者：

Zhou, C. ^{[1
]}

Caglevic, C. ^{[2
]}

Zhou, J. ^{[3
]}

Wang, B. ^{[4
]}

Wang, K. ^{[5
]}

Ge, J. ^{[6
]}

Zhou, Y. ^{[6
]}

Piperdi, B. ^{[7
]}

Ma, Z. ^{[8
]}

机构：

[1] Shanghai Pulm Hosp, Dept Oncol, Shanghai, Peoples R China

[2] FALP, Dept Oncol, Santiago, Chile

[3] Zhejiang Univ, Hosp 1, Dept Respirat, Hangzhou, Zhejiang, Peoples R China

[4] Subei Peoples Hosp, Dept Oncol, Yangzhou, Jiangsu, Peoples R China

[5] Zhejiang Univ, Hosp 2, Dept Respirat, Hangzhou, Zhejiang, Peoples R China

[6] MSD China, Oncol, Shanghai, Peoples R China

[7] Merck & Co Inc, Oncol, Kenilworth, NJ USA

[8] Henan Canc Hosp, Dept Oncol, Zhengzhou, Henan, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

466TiP

引用

页码：143 / 143

页数：1

共 50 条

[41] Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non-small-cell lung cancer [J].

Heymach, John V. ;

Johnson, Bruce E. ;

Prager, Diane ;

Csada, Edit ;

Roubec, Jaromir ;

Pesek, Milos ;

Spasova, Irena ;

Belani, Chandra P. ;

Bodrogi, Istvan ;

Gadgeel, Shirish ;

Kennedy, Sarah J. ;

Hou, Jeannie ;

Herbst, Roy S. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) :4270-4277

[42] Phase II clinical trial on docetaxel in the treatment of non-small-cell lung cancer (NSCLC). [J].

Chen, Y ;

Zhao, Y ;

Chen, Z ;

Liao, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :708S-708S

[43] ALUR: a phase 3 study of alectinib versus chemotherapy in previously treated ALK plus non-small cell lung cancer (NSCLC) [J].

Wolf, J. ;

Oh, I-J. ;

Mazieres, J. ;

de Castro, J. ;

Revil, C. ;

Kotb, A. ;

Johansdottir, H. ;

Zeaiter, A. ;

Novello, S. .

ANNALS OF ONCOLOGY, 2016, 27

[44] PEMETREXED IN PREVIOUSLY TREATED NON-SMALL-CELL LUNG CANCER [J].

Cho, E. ;

Hong, J. ;

Kim, Y. S. ;

Sim, S. J. ;

Park, S. H. ;

Park, J. ;

Lee, J. H. ;

Shin, D. B. .

ANNALS OF ONCOLOGY, 2008, 19 :120-120

[45] Carboplatin and paclitaxel for previously treated patients with non-small-cell lung cancer [J].

Roa, V ;

Conner, A ;

Mitchell, RB .

CANCER INVESTIGATION, 1998, 16 (06) :381-384

[46] Erlotinib in previously treated non-small-cell lung cancer [J].

Shepherd, FA ;

Pereira, JR ;

Ciuleanu, T ;

Tan, EH ;

Hirsh, V ;

Thongprasert, S ;

Campos, D ;

Maoleekoonpiroj, S ;

Smylie, M ;

Martins, R ;

van Kooten, M ;

Dediu, M ;

Findlay, B ;

Tu, DS ;

Johnston, D ;

Bezjak, A ;

Clark, G ;

Santabárbara, P ;

Seymour, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :123-132

[47] Vandetanib versus erlotinib in patients with previously treated advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial [J].

Goss, G. D. ;

Thongprasert, S. ;

Greco, F. A. ;

Thomas, M. ;

Tsai, C. M. ;

Sunpaweravong, P. ;

Ferry, D. ;

Gogov, S. ;

Rowbottom, J. A. ;

Natale, R. B. .

EJC SUPPLEMENTS, 2009, 7 (02) :506-506

[48] Phase I study of docetaxel and cisplatin for patients with previously untreated metastatic non-small-cell lung cancer: A Japanese cooperative study [J].

Segawa Y. ;

Watanabe K. ;

Hiraki S. ;

Tominaga K. ;

Hayashi I. ;

Harada M. ;

Yamakido M. ;

Ueda N. ;

Kashimura M. ;

Niitani H. .

International Journal of Clinical Oncology, 2000, 5 (5) :308-315

[49] Tislelizumab (TIS) versus docetaxel (D) in patients with previously treated advanced non-squamous (non-sq) non-small-cell lung cancer (NSCLC): Subanalysis from the RATIONALE-303 phase 3 randomized clinical study [J].

Cheng, Ying ;

Huang, Dingzhi ;

Ma, Zhiyong ;

Fan, Yun ;

Wang, Jie ;

Yu, Xinmin ;

Dvorkin, Mikhail ;

Rivalland, Gareth ;

Ma, Yiyuan ;

Wang, Yan ;

Ma, Yan ;

Zhou, Caicun .

CANCER RESEARCH, 2022, 82 (12)

[50] Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer NSCLC) [J].

Spicer, J. D. ;

Gao, S. ;

Liberman, M. ;

Kato, T. ;

Tsuboi, M. ;

Lee, S. H. ;

Chen, K. N. ;

Dooms, C. ;

Majem, M. ;

Eigendorff, E. ;

Martinengo, G. ;

Bylicki, O. ;

Garassino, M. C. ;

Abreu, D. Rodriguez ;

Chaft, J. ;

Novello, S. ;

Yang, J. ;

Keller, S. M. ;

Samkari, A. ;

Wakelee, H. .

ANNALS OF ONCOLOGY, 2023, 34 :S1297-S1298

← 1 2 3 4 5 →